Testimonial

Dr. Bishwapriya Deb exemplifies the spirit of leadership, innovation, and excellence fostered by IIM Kashipur’s EMBAA program. In January 2025, he was promoted to Director and Head of the Cardiometabolic Health Therapeutic Area at Eli Lilly, marking a significant milestone in his career.

He has received several prestigious recognitions, including Eli Lilly’s highest global honour, the President’s Award (2025), the ISCR Hall of Fame Award (2025), the Quality Pinnacle Award (2024), the Lilly Innovator Award, and the LRL Award for Advancing Science and Talent.

Beyond his corporate achievements, Dr. Deb serves as a Core Member of the Scientific Committee of the Indian Society of Clinical Research (ISCR), contributing to the advancement of clinical research in India.

His work in clinical data science and advanced analytics has helped accelerate the development of treatments for diabetes, obesity, and cardiovascular diseases, positively impacting patients worldwide.

Dr. Deb’s journey reflects a powerful blend of scientific expertise, leadership, and purpose-driven excellence, making him an inspiration to the IIM Kashipur community.